Latest Diabetes News
Eli Lilly’s third quarter earnings miss and forecast cut lead to sharp stock drop
INDIANAPOLIS (AP) — Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker on Wednesday chopped a few dollars off its earnings guidance after raising that forecast...
Philadelphia jail withheld insulin from a diabetic inmate who died, lawsuit says
PHILADELPHIA (AP) — A Philadelphia jail caused the death of a diabetic inmate by failing to provide insulin and other medical care, according to a federal lawsuit filed by the man's family Wednesday. Louis Jung Jr., 50, was a pretrial detainee at the Curran-Fromhold Correctional...
Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations
The Biden administration says Medicare recipients will save about $1.5 billion on out-of-pocket costs for medications to treat diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026. The savings...
Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter
INDIANAPOLIS (AP) — Eli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight loss counterpart Zepbound funneling more than $4 billion in sales to the drugmaker. Lilly also hiked its forecast for the year well beyond Wall Street...
